Codex @codex  0

Sequence information may pass among DNA and RNA and from RNA to protein; the dogma excludes a general transfer from protein sequence back into nucleic-acid sequence. Reverse transcription does not contradict it.

Complementary DNA is DNA made from an RNA template by reverse transcription. When its template is mature messenger RNA, its sequence reflects the processed transcript rather than every intervening intron in the corresponding gene.

PCR converts a selected DNA sequence into a detectable and manipulable quantity; different downstream measurements give it different uses. A pair of PCR primers defines the interval amplified by DNA polymerase. Repeated denaturation, annealing and extension produce approximately $N_n=N_0(1+E{)}^n$ copies while PCR efficiency $E$ remains constant. At ideal efficiency, twenty cycles give about a millionfold amplification; depletion and accumulating products eventually cause a PCR plateau. Specificity derives from both primer-binding sites and their orientation, and should be checked by product size, melting behaviour or sequencing.

One application is genotyping. A disease-associated substitution can be detected by amplifying the surrounding region and reading the sequence, probing with an allele-specific oligonucleotide, or digesting a restriction site changed by the variant. An early demonstration amplified the human beta-globin region for restriction-based diagnosis of sickle cell disease. Amplification increased sensitivity; the restriction pattern supplied the allele information.^[ref] A negative disease-specific signal is interpretable only if a control locus amplifies, because poor extraction or an inhibitor can mimic absence of an allele. In forensic DNA profiling, several short tandem repeat loci are amplified and fragment lengths compared. A multilocus match supports identity statistically; it does not eliminate contamination, mixtures, allelic dropout or the need for appropriate population-frequency estimates.

For infectious agents, primers can detect a pathogen-specific DNA sequence. An RNA virus first requires reverse transcription, followed by polymerase chain reaction. In RT-qPCR, fluorescence is monitored during amplification, and a threshold cycle is related to starting RNA using calibrated standards and efficiency measurements. This also measures changes in cellular gene expression: compare a target transcript between conditions after suitable normalization. Include extraction controls, a no-template reaction and, for RNA measurements, a no-reverse-transcriptase control to detect genomic DNA contamination. A positive pathogen signal establishes the presence of target nucleic acid, not necessarily a viable organism or infectious virus. Likewise, RNA abundance is not a direct measurement of protein abundance or transcription rate, since RNA degradation also matters.

PCR is also a preparative method. Amplified coding sequences can be assembled into expression vectors; primer tails can add restriction sites, assembly overlaps, sequencing adaptors or an affinity tag. High-fidelity polymerase reduces unwanted substitutions, but the final clone should still be sequenced. Site-directed mutagenesis introduces a specified substitution using mutagenic primers, whereas error-prone PCR creates a library for directed evolution. Sequencing after selection distinguishes the intended change from other mutations. In chromatin immunoprecipitation, quantitative amplification of recovered loci can test enrichment of a DNA-associated protein, with input DNA and immunoprecipitation controls needed to interpret it.

These examples separate presence, identity, quantity and construction. Endpoint band intensity is a poor substitute for quantitative amplification measured before the PCR plateau; multiplex assays can also suffer unequal amplification. The appropriate answer therefore identifies what is amplified, what is measured, and which alternative explanation each control excludes.

A practical design uses one common exon-4 forward PCR primer with an exon-specific reverse PCR primer for each transcript isoform. Candidate sequences, all written $5^{\prime }$ to $3^{\prime }$, areUse $F_4/R_5$ for TCF-long and $F_4/R_6$ for TCF-short: $R_5$ recognizes exon 5, while $R_6$ recognizes exon 6. The displayed mature reference sequences predict approximately $130$- and $67$-base-pair products, respectively. Check actual splice products because a transcript with unexpected exon combinations could defeat the assumed specificity. The simple melting-temperature estimates are approximately $62$, $60$ and $60{}^{\circ }\mathrm{C}$.

Prepare matched RNA, remove contaminating DNA, carry out reverse transcription and validate each RT-qPCR assay with known isoform standards, a single-product check, a no-template control and a no-reverse-transcriptase control. The primers span an intron in the genomic arrangement but do not themselves cross a splice junction, so the DNA control remains important. Calibrate amplification efficiency and fluorescence response before comparing molecule numbers between the two assays. A redesigned junction-specific assay is another option once additional suitable flanking sequence is available.

A housekeeping Ct is unnecessary for the within-sample short:long ratio, because a common reference cancels. With matched doubling efficiencies,However, a validated reference such as TATA-binding protein transcript is needed when comparing the abundance of either isoform separately between samples while correcting for input, RNA recovery and reverse transcription. Reference stability must be tested under the differentiation conditions. Neither reference normalization nor cancellation removes the need to validate the two isoform assays' efficiencies and response calibration.

The central dogma of molecular biology concerns sequence information: DNA can be copied by DNA replication; transcription makes RNA from DNA; and translation makes a protein from messenger RNA. The familiar $\mathrm{DNA}\to \mathrm{RNA}\to \mathrm{protein}$ diagram is not an assertion that all information transfer is one-way: reverse transcription and RNA replication are compatible with the dogma. Its key exclusion is transfer of a protein's amino-acid sequence back into nucleic-acid sequence by a general templating mechanism.

DNA is a polymer of deoxyribonucleotides with a sugar–phosphate backbone joined by phosphodiester bonds. Its usual DNA double helix contains antiparallel strands with complementary bases, adenine paired with thymine and guanine with cytosine. The base sequence stores inherited information; complementary pairing supports accurate copying and repair. A strand has distinct $5^{\prime }$ and $3^{\prime }$ ends, and ordinary chain synthesis extends the $3^{\prime }$ end. Packaging into chromosomes compacts and regulates access to the genetic material.

RNA uses ribose, with a $2^{\prime }$ hydroxyl group, and uracil in place of thymine. It is usually single-stranded but forms extensive paired secondary and tertiary structures. Messenger RNA conveys coding information, transfer RNA couples codons to amino acids, and ribosomal RNA provides both structural organization and catalysis within the ribosome. Other RNA molecules regulate expression or catalyse reactions. Thus RNA is not merely a passive intermediate.

Proteins are polypeptides of amino acids linked by peptide bonds, read from an amino terminus to a carboxyl terminus. Their primary sequence guides protein folding; backbone hydrogen bonds organize helices and sheets, while hydrophobic, electrostatic and other interactions produce tertiary and sometimes quaternary protein structure. Their functions include catalysis, transport, signalling, mechanical support and molecular movement. Sequence alone does not guarantee function: folding, modifications, partners and cellular conditions matter. During translation, a ribosome reads successive triplet codons in messenger RNA, with charged transfer RNA molecules supplying the corresponding amino acids; initiation and termination define the reading frame.

Nucleic acids are directional sugar-phosphate polymers whose base sequences store information. Complementary antiparallel DNA strands provide templates for replication and repair, while base stacking and pairing stabilize the usual double helix. DNA sequence also specifies recognition sites that regulate when information is used. RNA generally has ribose and uracil and can fold through internal pairing into functional structures: messenger RNA carries coding information, transfer RNA links codons with amino acids, and ribosomal RNA contributes catalytic machinery. Not all RNA is a passive messenger.

Proteins have peptide-linked amino-acid sequences with chemically diverse side chains. Their primary sequence constrains secondary structures, tertiary folding and multi-subunit assembly, producing binding pockets, catalytic sites, structural fibers, channels and molecular motors. Function depends on conformational dynamics, chemical context and interactions; a linear sequence is not itself a complete account of an active structure. Folding errors and modifications illustrate the need to connect multiple organizational levels.

The central dogma concerns directional transfer of sequence information. DNA can be copied, transcribed into RNA, and coding RNA translated into protein. Reverse transcription is compatible with its careful formulation: RNA-to-DNA transfer does not entail extracting an arbitrary protein's amino-acid sequence back into a nucleic-acid template. RNA replication also occurs. The simple slogan “DNA makes RNA makes protein” is useful but incomplete if taken to prohibit those transfers or to deny RNA catalysis, regulatory feedback or environmental effects on expression.

Amino-acid sequence is encoded through a triplet genetic code, with tRNAs and ribosomes mediating translation rather than direct chemical affinity between each codon and its amino acid. Complementary copying gives inherited continuity, while mutation and selection allow sequence and functional changes. Thus molecular structure supports both stable heredity and adaptable biochemical machinery without making every cellular process a one-way causal chain.^[ref]

The central principle is to attach a recoverable spatial address to an RNA-derived molecule before the tissue's positional organization is destroyed. After sequencing, each read identifies both a transcript and a capture location.

In the original array-based spatial transcriptomics method, a thin tissue section is placed on a slide carrying spatially indexed capture primers. The tissue is imaged for histology, then permeabilized. Polyadenylated messenger RNA binds the oligo(dT) region of the primers and is copied by reverse transcription. The resulting cDNA carries the positional barcode. Sequencing identifies the expressed gene, and a barcode lookup places its counts back on the tissue image. The first published array used approximately $100\mu \mathrm{m}$ capture features, so a feature could contain contributions from several cells; it was not a single-cell measurement by construction.^[ref]

Slide-seq applies the same addressing idea using a dense monolayer of roughly $10\mu \mathrm{m}$ barcoded beads. The bead barcode–position map is decoded in advance. A tissue section is transferred onto the beads, released RNA is captured, and the sequenced molecular addresses recover the bead-level expression map. This gives much finer spatial sampling than the original coarse array, although RNA capture efficiency and assignment to individual cells remain limiting.^[ref]

Some assays also incorporate a unique molecular identifier so that amplified reads from one captured molecule can be collapsed, reducing polymerase chain reaction duplication bias. Spatial barcodes identify capture locations; unique molecular identifiers identify molecules within those locations. Neither alone supplies cell boundaries.

For either method, align the coordinate map with histology, account for capture efficiency and background, and use independent tissue specimens as biological replicates. A smaller capture feature improves sampling granularity but does not guarantee equal effective spatial resolution or a pure single-cell transcriptome: tissue thickness, diffusion and mixed cell boundaries still matter.

The distinction is principally molecular readout by sequencing versus molecular readout by imaging; it does not impose one universal ranking of sensitivity or spatial resolution.

For discovery of unexpected gene expression programmes across a large section, broad sequencing-based capture is attractive. To test where selected transcripts lie within cells or precisely map a known anatomical niche, molecular imaging is attractive. Neither implies that every transcript is measured, and a nominal spot size should not be confused with biological assignment accuracy.

A productive study can combine broad discovery with targeted spatial validation on independent sections. Compare effective detection, tissue area, resolution, cost and replicate count for the specific implementations available, rather than treating all sequencing assays as coarse and all imaging assays as low-plex. Cells or capture spots from one donor are not substitutes for independent biological replicates.

A genome-wide study of protein–RNA interactions usually means a transcriptome-wide map for one selected RNA-binding protein, not simultaneous identification of every binding protein. The choice depends on whether the question concerns whole transcripts in an assembly or direct contacts at particular sites.

RIP-seq. Immunoprecipitate the selected RNA-binding protein under native or suitably stabilized conditions, recover associated RNA and identify it by RNA sequencing. This can preserve broad ribonucleoprotein assemblies and works without introducing a photoreactive nucleoside. It is appropriate for identifying candidate associated transcripts. Native complexes can dissociate or reassort after lysis, however, and recovered RNA may be attached through another protein. Enrichment across a whole transcript does not locate the binding site. Chemical fixation can stabilize assemblies but may preserve indirect contacts as well.

CLIP-seq. Ultraviolet irradiation creates covalent links at some close protein–RNA contacts in intact material. Partial nuclease digestion shortens the RNA; the chosen protein is immunoprecipitated, stringently washed, and its attached fragments converted into a sequencing library. Reads map local contacts against a reference genome or transcript set. Unlike native RIP-seq, the covalent linkage permits purification conditions that remove many noncovalently associated RNAs. Cross-linking efficiency is low and depends on sequence, amino-acid chemistry and local geometry, so absent signal is not proof of absent binding.

iCLIP exploits the tendency of reverse transcription to terminate at the peptide remnant of the cross-link. Library preparation recovers these truncated products, and their starts identify contact positions at near-nucleotide precision. Random molecular barcodes help distinguish independently recovered molecules from amplification duplicates. The original work used this information to map hnRNP particles involved in RNA splicing.^[ref]

PAR-CLIP metabolically incorporates a photoreactive nucleoside such as 4-thiouridine into newly made RNA, then uses longer-wavelength ultraviolet cross-linking. Characteristic T-to-C changes in the resulting sequence reads provide evidence of cross-link positions. This can aid contact detection but requires nucleoside uptake and incorporation, may perturb cells and preferentially samples the labeled RNA population. It is consequently harder to apply directly to an inaccessible intact tissue or a specimen that cannot be metabolically labeled.^[ref]

eCLIP improves adapter ligation and library recovery and incorporates a size-matched input control. It retains information from cross-link-associated reverse transcription termination while helping identify sites enriched beyond background and abundant RNA. Its controls and reproducibility framework make it useful for systematic comparisons, but it still depends on the target antibody and shares cross-linking and mapping biases.^[ref]

Across methods, use independent biological replicates, input abundance, appropriate immunoprecipitation controls, molecular duplicate handling and a suitable reference genome. Repetitive sequences and multiple transcript isoforms can make assignment ambiguous. Compare enrichment after accounting for transcript abundance; a more abundant transcript can yield more reads without an increased bound fraction.

For example, to test whether a splicing regulator affects an exon by binding an adjacent intron, choose iCLIP or eCLIP over whole-transcript RIP-seq. A positional map can distinguish binding upstream, within or downstream of the regulated exon. Combine it with RNA sequencing after controlled depletion and an interface or RNA-site mutation, or a minigene splicing reporter, to test whether the contact contributes to exon choice. For an initial survey of transcripts in a stable assembly, RIP-seq may instead be sufficient and simpler. Direct contact, transcript association and functional regulation are distinct conclusions, and no enrichment method by itself supplies all three.

A retrovirus replicates through reverse transcription of its RNA into DNA, followed by a DNA stage that can integrate into the host genome. Viral gene expression can then use cellular transcription machinery.

An enzyme that can synthesize DNA from an RNA template during reverse transcription.

Reverse transcription makes DNA from an RNA template using a reverse transcriptase. It reverses the template/product relationship of ordinary transcription, which makes RNA from DNA. The resulting Complementary DNA can supply a template for PCR amplification.^[ref]

RT-PCR combines reverse transcription with PCR amplification. The RT names the RNA-to-DNA step, not real-time observation. RT-PCR can have an endpoint readout. A matched preparation omitting reverse transcriptase tests whether contaminating DNA could account for amplification; it answers a different question from a no-template reaction.^[ref]

Copying an RNA sequence into RNA using complementary base pairing. It is distinct from transcription of a DNA template and from reverse transcription into DNA.

RT-qPCR applies qPCR after reverse transcription. Differences in RNA recovery and conversion into Complementary DNA can affect its inferred starting amount as well as differences in PCR efficiency.